Inflammatory Bowel Disease Biologics Market to Grow at 10.1% CAGR in India, Reaching USD 130.8 Billion by 2036, China - 9.9%, Germany - 7.9%
The inflammatory bowel disease biologics market is forecast to expand from USD 60.73 billion in 2026 to USD 130.81 billion by 2036, registering an 8.0% CAGR over the forecast period. Fact.MR attributes this expansion to the rising prevalence and diagnosis of inflammatory bowel disease, increasing adoption of biologics for moderate-to-severe cases, and the continued introduction of therapies...
0 Комментарии 0 Поделились 335 Просмотры 0 предпросмотр